tiprankstipranks
Trending News
More News >
Fusion Antibodies Plc (GB:FAB)
:FAB
UK Market
Advertisement

Fusion Antibodies Plc (FAB) Income Statement

Compare
7 Followers

Fusion Antibodies Plc Income Statement

Last quarter (Q4 2024), Fusion Antibodies Plc's total revenue was £758.00K, a decrease of -26.97% from the same quarter last year. In Q4, Fusion Antibodies Plc's net income was £-955.00K. See Fusion Antibodies Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 1.97M£ 1.14M£ 2.90M£ 4.80M£ 4.17M
Gross Profit
£ 430.00K£ -265.00K£ 202.00K£ 1.72M£ 1.31M
Operating Expenses
£ 2.21M£ 2.24M£ 3.04M£ 3.05M£ 2.69M
Depreciation and Amortization
£ 102.00K£ 219.00K£ 372.00K£ 751.00K£ 714.00K
EBITDA
£ -1.62M£ -2.06M£ -2.48M£ -573.00K£ -532.00K
Operating Income
£ -1.78M£ -2.29M£ -2.83M£ -1.33M£ -1.38M
Other Income/Expenses
£ 2.00K£ -1.00K£ -1.00K£ -8.00K£ -15.00K
Pretax Income
£ -1.78M£ -2.29M£ -2.86M£ -1.33M£ -1.26M
Net Income
£ -1.71M£ -2.23M£ -2.60M£ -1.20M£ -2.90M
Per Share Metrics
Basic EPS
£ -0.02£ -0.04£ -0.10£ -0.05£ -0.11
Diluted EPS
£ -0.02£ -0.04£ -0.10£ -0.05£ -0.11
Weighted Average Shares Outstanding
95.88M 55.56M 26.01M 25.95M 25.46M
Weighted Average Shares Outstanding (Diluted)
95.88M 55.56M 26.01M 25.95M 25.46M
Currency in GBP

Fusion Antibodies Plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis